| Excess cancers among HIV-infected people in the United States HA Robbins, RM Pfeiffer, MS Shiels, J Li, HI Hall, EA Engels Journal of the National Cancer Institute 107 (4), dju503, 2015 | 274 | 2015 |
| Epidemiologic contributions to recent cancer trends among HIV-infected people in the United States HA Robbins, MS Shiels, RM Pfeiffer, EA Engels Aids 28 (6), 881-890, 2014 | 274 | 2014 |
| Risk of merkel cell carcinoma after solid organ transplantation CA Clarke, HA Robbins, Z Tatalovich, CF Lynch, KS Pawlish, JL Finch, ... Journal of the National Cancer Institute 107 (2), dju382, 2015 | 224 | 2015 |
| Melanoma risk and survival among organ transplant recipients HA Robbins, CA Clarke, ST Arron, Z Tatalovich, AR Kahn, BY Hernandez, ... Journal of investigative dermatology 135 (11), 2657-2665, 2015 | 142 | 2015 |
| Risk of colorectal cancer after solid organ transplantation in the United States M Safaeian, HA Robbins, SI Berndt, CF Lynch, JF Fraumeni Jr, EA Engels American journal of transplantation 16 (3), 960-967, 2016 | 103 | 2016 |
| Using prediction models to reduce persistent racial and ethnic disparities in the draft 2020 USPSTF lung cancer screening guidelines R Landy, CD Young, M Skarzynski, LC Cheung, CD Berg, MP Rivera, ... JNCI: Journal of the National Cancer Institute 113 (11), 1590-1594, 2021 | 94 | 2021 |
| Sensitivity and specificity of oral HPV detection for HPV-positive head and neck cancer BJ Gipson, HA Robbins, C Fakhry, G D'Souza Oral oncology 77, 52-56, 2018 | 83 | 2018 |
| Age at cancer diagnosis for blacks compared with whites in the United States HA Robbins, EA Engels, RM Pfeiffer, MS Shiels Journal of the National Cancer Institute 107 (3), dju489, 2015 | 70 | 2015 |
| Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium AR Kreimer, A Ferreiro-Iglesias, M Nygard, N Bender, L Schroeder, ... Annals of Oncology 30 (8), 1335-1343, 2019 | 68 | 2019 |
| Tobacco smoking and risk of second primary lung cancer JV Aredo, SJ Luo, RM Gardner, N Sanyal, E Choi, TP Hickey, TL Riley, ... Journal of Thoracic Oncology 16 (6), 968-979, 2021 | 65 | 2021 |
| Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result HA Robbins, CD Berg, LC Cheung, AK Chaturvedi, HA Katki JNCI: Journal of the National Cancer Institute 111 (9), 996-999, 2019 | 56 | 2019 |
| Population-based precision cancer screening: a symposium on evidence, epidemiology, and next steps PM Marcus, N Pashayan, TR Church, VP Doria-Rose, MK Gould, ... Cancer Epidemiology, Biomarkers & Prevention 25 (11), 1449-1455, 2016 | 55 | 2016 |
| Analysis of lung cancer risk model (PLCOM2012 and LLPv2) performance in a community-based lung cancer screening programme MB Lebrett, H Balata, M Evison, D Colligan, R Duerden, P Elton, ... Thorax 75 (8), 661-668, 2020 | 39 | 2020 |
| Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom HA Robbins, K Alcala, AJ Swerdlow, MJ Schoemaker, N Wareham, ... British Journal of Cancer 124 (12), 2026-2034, 2021 | 38 | 2021 |
| Patient experience and anxiety during and after treatment for an HPV-related oropharyngeal cancer G D’Souza, Y Zhang, S Merritt, D Gold, HA Robbins, V Buckman, J Gerber, ... Oral oncology 60, 90-95, 2016 | 32 | 2016 |
| Cervical cancer screening intervals and management for women living with HIV: a risk benchmarking approach HA Robbins, HD Strickler, LS Massad, CB Pierce, TM Darragh, H Minkoff, ... Aids 31 (7), 1035-1044, 2017 | 30 | 2017 |
| Benefits and harms in the National Lung Screening Trial: expected outcomes with a modern management protocol HA Robbins, M Callister, P Sasieni, SL Quaife, LC Cheung, P Brennan, ... The lancet respiratory medicine 7 (8), 655-656, 2019 | 27 | 2019 |
| Glutathione S-transferase L1 multiplex serology as a measure of cumulative infection with human papillomavirus HA Robbins, Y Li, C Porras, M Pawlita, A Ghosh, AC Rodriguez, ... BMC infectious diseases 14, 1-11, 2014 | 26 | 2014 |
| Comparison of antibody responses to human papillomavirus vaccination as measured by three assays HA Robbins, TJ Kemp, C Porras, AC Rodriguez, M Schiffman, ... Frontiers in oncology 3, 328, 2014 | 26 | 2014 |
| Absolute risk of oropharyngeal cancer after an HPV16-E6 serology test and potential implications for screening: results from the human papillomavirus cancer cohort consortium HA Robbins, A Ferreiro-Iglesias, T Waterboer, N Brenner, M Nygard, ... Journal of Clinical Oncology 40 (31), 3613, 2022 | 24 | 2022 |
Mattias JohanssonInternational Agency for Research on Cancer (IARC)Verified email at iarc.fr
